Travere therapeutics and csl vifor announce european commission approves filspari® (sparsentan) for the treatment of iga nephropathy

Travere and csl vifor announce ec approval of filspari (sparsentan) for treatment of igan, 1st non-immunosuppressive treatment for igan approved in europe

TVTX Ratings Summary

TVTX Quant Ranking